Publikationen in Zusammenarbeit mit Forschern von Queen's University (25)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2016

  1. Discrimination in the workplace, reported by people with major depressive disorder: A cross-sectional study in 35 countries

    BMJ Open, Vol. 6, Núm. 2

2015

  1. Cross-national variations in reported discrimination among people treated for major depression worldwide: The ASPEN/INDIGO international study

    British Journal of Psychiatry, Vol. 207, Núm. 6, pp. 507-514

2013

  1. Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: A cross-sectional survey

    The Lancet, Vol. 381, Núm. 9860, pp. 55-62

2011

  1. Staging neurodegenerative disorders: Structural, regional, biomarker, and functional progressions

    Neurotoxicity Research, Vol. 19, Núm. 2, pp. 211-234

2010

  1. Clinical staging in the pathophysiology of psychotic and affective disorders: Facilitation of prognosis and treatment

    Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 211-228

  2. Epigenetics and biomarkers in the staging of neuropsychiatric disorders

    Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 347-366

  3. Staging perspectives in neurodevelopmental aspects of neuropsychiatry: Agents, phases and ages at expression

    Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 287-305

2008

  1. Affective status in relation to impulsive, motor and motivational symptoms: Personality, development and physical exercise

    Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 151-168

  2. Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control

    Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 205-225

  3. Focusing on symptoms rather than diagnoses in brain dysfunction: Conscious and nonconscious expression in impulsiveness and decision-making

    Neurotoxicity Research, Vol. 14, Núm. 1, pp. 1-20

  4. Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths

    Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 79-96

2007

  1. Comorbidity implications in brain disease: Neuronal substrates of symptom profiles

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 1-15

  2. Comorbidity of substance abuse with other psychiatric disorders

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 17-27

  3. Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 29-42

  4. Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders

    Neurotoxicity Research, Vol. 12, Núm. 1, pp. 43-60

2004

  1. Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes

    Neurotoxicity Research, Vol. 6, Núm. 3, pp. 159-173

  2. Gene-environment interplay in alcoholism and other substance abuse disorders: Expressions of heritability and factors influencing vulnerabilities

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 343-361